139 -2 (88) 2026 - Askarova Z.Z., Fayzullaeva N.A. - THE SIGNIFICANCE OF COMPREHENSIVE ULTRASONOGRAPHY IN DETECTING ADENOMYOSIS IN PERIMENOPAUSAL WOMEN

THE SIGNIFICANCE OF COMPREHENSIVE ULTRASONOGRAPHY IN DETECTING ADENOMYOSIS IN PERIMENOPAUSAL WOMEN

Askarova Z.Z. - Samarkand State Medical University

Fayzullaeva N.A. - Samarkand State Medical University

Resume

A total of 120 perimenopausal patients were included in the study. Among them, 70 women were diagnosed with adenomyosis, and 50 perimenopausal women without gynecological diseases underwent examination and treatment in the gynecology department of the multidisciplinary clinic of Samarkand State Medical University between 2023 and 2025. Additionally, 45 medical records of perimenopausal women with histologically confirmed adenomyosis were analyzed retrospectively. It was found that the combination of adenomyosis with uterine fibroids occurred significantly more often in the main group — in 28 patients (40 ± 5.9%) compared to 9 cases (20 ± 6%) in the comparison group (p < 0.05). A comparison of ultrasound elastography data with histological findings of resected tissues demonstrated high diagnostic accuracy of the method: overall accuracy — 88.6%, sensitivity — 94.1%, specificity — 85%, positive predictive value — 80%, and negative predictive value — 95.8%. The obtained results confirm the high informativeness and effectiveness of comprehensive ultrasound examination, including elastography, in diagnosing adenomyosis and determining its degree in perimenopausal women.

Keywords: adenomyosis, perimenopause, ultrasound diagnostics, elastography, uterine fibroid, histological study

First page

739

Last page

745

For citation:Askarova Z.Z., Fayzullaeva N.A. - THE SIGNIFICANCE OF COMPREHENSIVE ULTRASONOGRAPHY IN DETECTING ADENOMYOSIS IN PERIMENOPAUSAL WOMEN//New Day in Medicine 2(88)2026 739-745 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

  1. Балан ВЕ, Тихомирова ЕВ. Менопаузальная гормонотерапия: максимальная польза при минимальных рисках. Медицинский алфавит. 2018;1(6(343)):6–9.
  2. Говоров ИЕ, Калинина ЕА, Ситкин СИ, и др. Метаболомные маркеры онкогинекологических заболеваний. Лечение и профилактика. 2018;8(3):54–60.
  3. Денисова ВМ, Ярмолинская МИ. Наружный генитальный эндометриоз: различные грани проблемы. Журнал акушерства и женских болезней. 2015;64(1):44–52.
  4. Доброхотова ЮЭ, Ибрагимова ДМ, Гришин ИИ. Меноррагия: есть ли пути решения? Медицинский совет. 2016;(12):12–13.
  5. Хохлова СВ. Иммунотерапия и рак эндометрия [Интернет]. Доступно по адресу: https://rosoncoweb.ru/news/oncology/2020/03/10-2/
  6. Чернуха ГЕ, Асатурова АВ, Иванов ИА, Коршунов АА. К вопросу о гормональной чувствительности полипов эндометрия и эффективности применения левоноргестрел-содержащей внутриматочной системы в качестве метода вторичной профилактики. Акушерство и гинекология. 2020;(6):65–71.
  7. Kopelman A, Girao MJ, Bonetti TC, et al. Analysis of gene expression in the endocervical epithelium of women with deep endometriosis. Reprod Sci. 2016;23(9):1269–1274.
  8. Adams C, Brooks T. Adenomyosis: Clinical implications of immunity. Clin Med. 2021;21(4):289–295. doi:10.7861/clinmed.2021-0123
  9. Wang C, Tran DA, Fu MZ, Chen W, Fu SW, Li X. Estrogen receptor, progesterone receptor, and HER2 receptor markers in endometrial cancer. J Cancer. 2020;11(7):1693–1701. doi:10.7150/jca.41943
  10. Weigel NL, Acevedo-Rodriguez A, Mani SK. Steroid receptor crosstalk with cellular signaling pathways. In: Reference Module in Neuroscience and Biobehavioral Psychology. 2017.
  11. Wise J. Women with endometriosis show higher risk for heart disease. BMJ. 2016;353:i1851.
  12. World Health Organization. Women’s health [Internet]. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/women-s-health

    file

    download